Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765037 · ClinicalTrials.gov registry record
Retrospective Encore Reverse Shoulder Prosthesis Study
A clinical trial of Glenohumeral Arthritis and Rotator Cuff Deficiency, sponsored by Encore Medical, L.P..
- Completed
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT00765037: Completed study of Glenohumeral Arthritis and Rotator Cuff Deficiency, sponsored by Encore Medical, L.P..
NCT00765037 is a study of Glenohumeral Arthritis and Rotator Cuff Deficiency that has completed, run by Encore Medical, L.P.. The registered enrollment target is 19 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00765037, a study of Glenohumeral Arthritis and Rotator Cuff Deficiency, has completed, sponsored by Encore Medical, L.P..
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already begun.
Primary Outcome
Number of subjects who completed all study visits through the 1 year visit.
Conditions Studied
Interventions
- DEVICE Encore Reverse Shoulder Prosthesis
Study Locations (1)
Tennessee
- Nashville Orthopedic Specialists - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-05 |
What the finished NCT00765037 record still lists
NCT00765037 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 2 conditions, with Glenohumeral Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Encore Reverse Shoulder Prosthesis is the first listed.
NCT00765037 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00765037 about?
NCT00765037 is a clinical study titled "Retrospective Encore Reverse Shoulder Prosthesis Study". The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already begun.
What is the current status of trial NCT00765037?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2008-08. Estimated completion is 2009-05.
What conditions does trial NCT00765037 study?
This clinical trial studies the following conditions: Glenohumeral Arthritis, Rotator Cuff Deficiency.
What interventions are being tested in trial NCT00765037?
The interventions under investigation include: Encore Reverse Shoulder Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT00765037?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00765037 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glenohumeral Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia